Insiders · Profile

BROSHY ERAN

Director at Theravance Biopharma · Director at Certara. Filing since 21 Aug 2023. CIK 0001256230

Company
Date
Role
Action
Shares
Amount
Of holding
26 Nov 2025
Director
Sold on a plan
29,501
$590.02K
39.8%
11 Nov 2025
Director
Sold at will
59,000
$1.07M
56.1%
22 Aug 2023
Director
Bought
4,807
$75.95K
50.3%
21 Aug 2023
Director
Bought
193
$3.11K
2.1%
4 decisions on file.